News / Events Press Releases IR Calendar Audio and Video Email Alerts All News 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Search terms Pressure BioSciences, Inc. Reports 69% Revenue Increase for Q1 2012 May 16, 2012 Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update May 15, 2012 Pressure BioSciences, Inc. and LEAP Technologies, Inc. Announce Co-Development, Co-Marketing, & Co-Selling Agreement May 7, 2012 Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDI's Planned Offering of Personalized Medicine Clinical Diagnostic Services Apr 23, 2012 Ironridge BioPharma to Invest $500,000 in Pressure BioSciences Apr 9, 2012 Pressure BioSciences Common Stock to Begin Trading Today on the OTCQB(TM) Tier of the OTC Marketplace Apr 5, 2012 Dr. Henry C. Lee, One of the World's Leading Forensic Scientists, to Investigate the Use of Pressure BioSciences' Enabling Pressure Cycling Technology ("PCT") Platform for Use in Multiple Areas of Forensic Analysis Mar 9, 2012 NASDAQ Panel Grants Pressure BioSciences' Request for Continued Listing Pursuant to an Extension Mar 8, 2012 New Data Indicate Pressure BioSciences' Novel Technology Platform Offers Great Promise to the Areas of Biomarker Discovery and Drug Development Mar 7, 2012 Pressure BioSciences, Inc. Continues Expansion of European Sales Reach With Distribution Agreement for the Benelux Countries Mar 1, 2012 1... 29 30 31 32 33 34 35 36 37 38 ...47
Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update May 15, 2012
Pressure BioSciences, Inc. and LEAP Technologies, Inc. Announce Co-Development, Co-Marketing, & Co-Selling Agreement May 7, 2012
Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDI's Planned Offering of Personalized Medicine Clinical Diagnostic Services Apr 23, 2012
Pressure BioSciences Common Stock to Begin Trading Today on the OTCQB(TM) Tier of the OTC Marketplace Apr 5, 2012
Dr. Henry C. Lee, One of the World's Leading Forensic Scientists, to Investigate the Use of Pressure BioSciences' Enabling Pressure Cycling Technology ("PCT") Platform for Use in Multiple Areas of Forensic Analysis Mar 9, 2012
NASDAQ Panel Grants Pressure BioSciences' Request for Continued Listing Pursuant to an Extension Mar 8, 2012
New Data Indicate Pressure BioSciences' Novel Technology Platform Offers Great Promise to the Areas of Biomarker Discovery and Drug Development Mar 7, 2012
Pressure BioSciences, Inc. Continues Expansion of European Sales Reach With Distribution Agreement for the Benelux Countries Mar 1, 2012